SEARCH:

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, May 23, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 

1.

Details of the person discharging managerial responsibilities/person closely associated  

a)

Name

Jean-Christophe May

2.

Reason for the notification

a)

Position/status

Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Shares



DK0015998017

b)

Nature of the transaction

Exercise of warrants

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 155.80

9,000

d)

Aggregated information

-       Aggregated volume

-       Price

 

9,000

DKK 1,402,200.00

e)

Date of the transaction

2023-05-23

f)

Place of the transaction

Nasdaq Copenhagen A/S, XCSE

 

1.

Details of the person discharging managerial responsibilities/person closely associated  

a)

Name

Jean-Christophe May

2.

Reason for the notification

a)

Position/status

Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Shares



DK0015998017

b)

Nature of the transaction

Sale

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 207.38

9,000

d)

Aggregated information

-       Aggregated volume

-       Price

 

9,000

DKK 1,866,394.80

e)

Date of the transaction

2023-05-23

f)

Place of the transaction

Nasdaq Copenhagen A/S, XCSE

 

About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the research and development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. Using our live virus vaccine platform technology, MVA-BN® and in-licensed technologies, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system. For more information visit www.bavarian-nordic.com.

Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

Company Announcement no. 22 / 2023

Published on May 23, 2023, 18:00 CET